GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Schedule of meet
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
GlaxoSmithKline Pharmaceuticals Limited has informed the stock exchanges about an upcoming analyst and institutional investor meeting scheduled for 13th May 2025. The interaction will be a group meeting held digitally with investors and analysts. The company has clarified that only information already available in the public domain will be shared during this meeting, with no new material disclosures expected. The filing is a routine compliance requirement under SEBI Listing Regulations. The company has also noted that the date is subject to change due to scheduling exigencies.
This is a routine regulatory disclosure with no new material information being shared, so it is unlikely to have any meaningful impact on the stock price. Investors may monitor the meeting for management tone, but no fresh data or guidance is expected.